Skip to main content

EDITORIAL article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | doi: 10.3389/fmolb.2024.1497754
This article is part of the Research Topic Revisiting the Challenges and Opportunities in Cancer Drug Resistance View all 6 articles

Editorial: Revisiting the Challenges and Opportunities in Cancer Drug Resistance

Provisionally accepted
Tikam C. Dakal Tikam C. Dakal 1*Narendra K. Sharma Narendra K. Sharma 2Amit Sharma Amit Sharma 3
  • 1 Department of Biotechnology, Faculty of Science, Mohanlal Sukhadia University, Udaipur, India
  • 2 Department of Bioscience and Biotechnology, Banasthali University, Vanasthali, Rajasthan, India
  • 3 University of Bonn, Bonn, North Rhine-Westphalia, Germany

The final, formatted version of the article will be published soon.

    Keywords: Cancer, Drug Resistance, Challenges, Precision Medicine, Treatment

    Received: 17 Sep 2024; Accepted: 19 Sep 2024.

    Copyright: © 2024 Dakal, Sharma and Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Tikam C. Dakal, Department of Biotechnology, Faculty of Science, Mohanlal Sukhadia University, Udaipur, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.